Navigation Links
Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis

red by insurance, dependence on the effectiveness of our patents and other protections for innovative products, significant operations worldwide that may be adversely affected by terrorism, political or economical instability or major hostilities, supply interruptions or delays that could result from the complex manufacturing of our products and our global supply chain, environmental risks, fluctuations in currency, exchange and interest rates, and other factors that are discussed in Teva's Annual Report on Form 20-F and its other filings with the U.S. Securities and Exchange Commission. Forward-looking statements speak only as of the date on which they are made and the Company undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

# # #

EMBARGOED UNTIL FRIDAY, MAY 4, 8:00 AM, ET

COPAXONE(r) TREATMENT OVER TWO YEARS AFTER SHORT TERM INDUCTION WITH MITOXANTRONE PROVIDED SUSTAINED BENEFITS TO ACTIVE RELAPSING-REMITTING MULTIPLE SCLEROSIS PATIENTS

Increased efficacy on MRI and clinical outcomes achieved at 15 months was sustained for 24 months in follow-up study

Kansas City, Mo, May 4, 2007 - New data have demonstrated that relapsing-remitting multiple sclerosis (RRMS) patients treated with COPAXONE(r) (glatiramer acetate injection) following brief immunosuppression with mitoxantrone experienced a 90 percent reduction in magnetic resonance imaging (MRI)-monitored disease activity compared to their baseline. These benefits were achieved early on and were sustained throughout the 24-month study period. These long-term data were consistent with the 15-month initial results of this study, previously presented at an international meeting on multiple sclerosis (MS), which demonstrated that the induction treatment strategy was more effective than COPAXONE(r) alone on reducing relapses and MRI measures of disease activity (p=0.0147). Treatment with COPAXO
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Point of Care Strep Tests Speed Treatment, Lower Costs
2. Rapid HIV Testing Increases Possibility of Treatment
3. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
4. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
5. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
6. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
7. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
8. TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
9. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
10. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
11. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
Post Your Comments:
(Date:8/21/2014)... ON , Aug. 21, 2014 /CNW/ - Eisai Limited ... the introduction of the first-of-its-kind comic book available in ... tool, has been designed specifically to educate children and their ... Canada affecting more than 300,000 Canadians. Eisai ... health care (hhc) , in which the patient is central ...
(Date:8/21/2014)... Mass. , Aug. 21, 2014  Decision ... COPD,  physicians in Brazil ... follow clinical guidelines and commonly prescribe long-acting beta-agonist ... although they do so within current severe cost/coverage ... (FDCs) that are expected to launch in these ...
(Date:8/21/2014)... ARMONK , N.Y. and HAMBURG, Germany ... today announced it is collaborating with Deutsches Elektronen-Synchrotron ( ... Germany , to speed up management and ... Big Data and Analytics architecture based on ... gigabyte per second of data at peak performance and ...
Breaking Medicine Technology:Eisai Pleased to Support Canadian Epilepsy Alliance Comic Book that Teaches Children About Epilepsy 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 3DESY and IBM Develop Big Data Architecture for Science 2DESY and IBM Develop Big Data Architecture for Science 3
... , THE WOODLANDS, Texas , Feb. ... ), a biopharmaceutical company focused on discovering and developing breakthrough treatments ... Ph.D. , Lexicon,s president and chief executive officer, will present at ... on Monday, February 8, 2010 at 9:30 ...
... , BATESVILLE, Ind. , Feb. 3 , ... , Reported diluted earnings per share were $0.31 ... share of $0.23 in the prior year , ... , Company updates annual guidance for fiscal year 2010:  Reaffirms ...
Cached Medicine Technology:Lexicon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference 2Lexicon Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference 3Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter 2Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter 3Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter 4Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter 5Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter 6Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter 7Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter 8Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter 9Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter 10Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter 11Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter 12Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter 13Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter 14Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter 15Hill-Rom Reports Double Digit Earnings Per Share Growth for First Quarter 16
(Date:8/22/2014)... CA (PRWEB) August 22, 2014 Buying a ... an adult who is unsure about available coverage types by ... providing principal life insurance policy pricing to the public using ... use of this tool is free and is expected to ... available to the public throughout the U.S. The system is ...
(Date:8/22/2014)... The regional economy is about to get ... the grow again. The plant will invest $100 ... boost production of the popular Highlander midsize sport utility ... to $4 billion. This step allows Toyota to utilize ... to adjust its product mix to meet changing customer ...
(Date:8/22/2014)... York (PRWEB) August 22, 2014 ... morcellators ( http://www.injurybeacon.com/power-morcellator/ ) in uterine surgeries continues ... Massachusetts insurance companies have decided to limit coverage ... the Worcester Telegram, Blue Cross-Blue Shield of Massachusetts ... surgeries that involve morcellation as of September 1, ...
(Date:8/22/2014)... Bcl-2-like protein 11 (BIM) deletion in advanced ... shorter progression free survival (PFS) in epidermal growth ... chemotherapy treated Asian patients. Also, BIM deletion independently ... , The BIM protein can activate the programmed ... in cells. BIM deletion has been detected in ...
(Date:8/22/2014)... 22, 2014 Restore My Vision ... Dr. Samantha Pearson to help people discover how they ... vision surgery by instead improving their eyesight naturally has ... review. , “There’s a reason why the glasses ... each year—it’s because people just assume that it’s their ...
Breaking Medicine News(10 mins):Health News:Principal Life Insurance Policies Now Quoted for Adults at Insurance Website Online 2Health News:Toyota Indiana Adding 300 Jobs to Build More Highlanders 2Health News:As Power Morcellator Controversy Grows, Bernstein Liebhard LLP Comments on Massachusetts Insurers’ Plans to Limit Coverage of Uterine Morcellation 2Health News:As Power Morcellator Controversy Grows, Bernstein Liebhard LLP Comments on Massachusetts Insurers’ Plans to Limit Coverage of Uterine Morcellation 3Health News:As Power Morcellator Controversy Grows, Bernstein Liebhard LLP Comments on Massachusetts Insurers’ Plans to Limit Coverage of Uterine Morcellation 4Health News:Deletion predicts survival in advanced non-small cell lung cancer 2Health News:Restore My Vision Today: Review Exposes Natural Eye Restoration Guide by Dr. Sen and Dr. Samantha Pearson 2
... GapCHICAGO, April 9 /PRNewswire/ -- The ... Aid as the organization tries to help 40,000 children and ... Children,s Home + Aid,s revenue is falling $800,000 short ... funding, a 30% decline in the value of its endowment ...
... According to Drs. Timothy Salthouse and Eric R. ... less effective as early as our mid-twenties. A ... of Virginia professor of psychology and the study,s ... to make rapid comparisons, remember unrelated information, and detect ...
... International has named Melvin H. Stein Executive Vice President. In ... and marketing efforts in the worksite, medical clinic, health club and ... ... April 9, 2009 -- Lifeclinic International has named Melvin ...
... echo those of an American team , , THURSDAY, April ... earlier than it does for many patients, say researchers who ... and North America. , The new findings come on the ... New England Journal of Medicine . In that study, ...
... Inc. (OTC Bulletin Board: NVLX), formerly eFoodSafety.com, an ... of aesthetics, dermatology, environmental and nutraceutical products, announced ... the Company,s joint venture marketing partner for purEffectTM, ... sales of purEffect through the product,s website ( ...
... 9 San Antonio based HomeSwimmer, Ltd. and Olympic ... an endorsement agreement for the promotion of the firm,s ... were not released.(Photo: http://www.newscom.com/cgi-bin/prnh/20090409/CL96285 ... in Sydney in 2000 where he was elected Captain ...
Cached Medicine News:Health News:Children's Home + Aid Faces Revenue Shortfall 2Health News:According To a New Study, Cognitive Abilities Begin to Deteriorate Around the Age of 27 2Health News:Lifeclinic Names New Executive Vice President as its Presence in Non-Retail Wellness Sector Grows 2Health News:Another Study Supports Early HIV Therapy 2Health News:Another Study Supports Early HIV Therapy 3Health News:Nuvilex, Inc.'s Marketing Partner, CK41 to Launch purEffect(TM) in May 2Health News:Nuvilex, Inc.'s Marketing Partner, CK41 to Launch purEffect(TM) in May 3Health News:Nuvilex, Inc.'s Marketing Partner, CK41 to Launch purEffect(TM) in May 4Health News:Nuvilex, Inc.'s Marketing Partner, CK41 to Launch purEffect(TM) in May 5Health News:HomeSwimmer, Ltd. Signs Olympic Medalist Josh Davis 2
Designed for young and disabled children but equally suitable for older children and adults., ,Optional 6/60 to 6/24 booklet available for patients who fail standard screening test and require fu...
... The RX ACCULINK Carotid Stent System is designed ... patients who have carotid atherosclerosis and are at ... guide wire compatible RX ACCULINK Carotid Stent System ... available stent sizes. The RX ACCULINK utilizes rapid ...
Tests for protan and deutan defects. Patients must identify numbers or patterns formed in a matrix of small colored dots varying in color and intensity. Two editions available: 38 plate for detailed ...
The Cryomatic console employs smart technology...
Medicine Products: